In today’s trading, shares of Expedia Group Inc (Symbol: EXPE) have risen above the average analyst 12-month target of $189.39, currently priced at $202.37 per share. Typically, when a stock meets an analyst’s target, they face two choices: either downgrade the stock due to valuation concerns or update the target price to reflect new expectations. The decision may also hinge on the company’s latest performance and market conditions, which could justify a higher valuation.
According to Zacks’ coverage, 33 analysts have set various targets for Expedia Group Inc. This average reflects a range of opinions—some analysts anticipate the stock could pull back, with one target set as low as $156.00, while another foresees a much more optimistic target of $236.00. The standard deviation among these targets is $21.13, highlighting the differences in analyst sentiment.
The purpose behind examining the average price target for EXPE is to gauge the ‘wisdom of crowds,’ benefitting from the combined insights of multiple analysts rather than relying solely on the view of an individual expert. With the stock now exceeding the average target price of $189.39, investors may want to reconsider their approach. Is the average target merely a stepping stone to a higher mark, or does it indicate a potential overvaluation that prompts taking profits? Below is a table summarizing the current ratings from analysts covering Expedia Group Inc:
| Recent EXPE Analyst Ratings Breakdown | ||||
|---|---|---|---|---|
| » | Current | 1 Month Ago | 2 Months Ago | 3 Months Ago |
| Strong buy ratings: | 10 | 10 | 8 | 7 |
| Buy ratings: | 1 | 1 | 1 | 1 |
| Hold ratings: | 21 | 21 | 23 | 23 |
| Sell ratings: | 0 | 0 | 0 | 0 |
| Strong sell ratings: | 0 | 0 | 0 | 0 |
| Average rating: | 2.34 | 2.34 | 2.47 | 2.52 |
The average rating is measured from 1 to 5, where 1 signifies a Strong Buy and 5 reflects a Strong Sell. This analysis incorporates data provided by Zacks Investment Research via Quandl.com. For those interested, the latest Zacks research report on EXPE is available for free.
10 ETFs With Most Upside To Analyst Targets »
Also see:
· Molina Healthcare 13F Filers
· CVBF Options Chain
· VPU shares outstanding history
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
